MENU
+Compare
NEPH
Stock ticker: NASDAQ
AS OF
Aug 11, 04:59 PM (EDT)
Price
$4.49
Change
+$0.59 (+15.13%)
Capitalization
41.34M

NEPH Nephros Forecast, Technical & Fundamental Analysis

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets... Show more

NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for NEPH with price predictions
Aug 08, 2025

NEPH in downward trend: 10-day moving average crossed below 50-day moving average on July 31, 2025

The 10-day moving average for NEPH crossed bearishly below the 50-day moving average on July 31, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NEPH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NEPH entered a downward trend on August 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where NEPH's RSI Indicator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 63 cases where NEPH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on August 08, 2025. You may want to consider a long position or call options on NEPH as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

NEPH moved above its 50-day moving average on August 08, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NEPH advanced for three days, in of 199 cases, the price rose further within the following month. The odds of a continued upward trend are .

NEPH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NEPH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.450) is normal, around the industry mean (10.661). P/E Ratio (48.750) is within average values for comparable stocks, (62.050). NEPH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.847). NEPH has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (2.672) is also within normal values, averaging (83.916).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NEPH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
NEPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

NEPH is expected to report earnings to fall 175.00% to -1 cents per share on November 06

Nephros NEPH Stock Earnings Reports
Q3'25
Est.
$-0.01
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.05
Q4'24
Beat
by $0.05
Q3'24
Beat
by $0.04
The last earnings report on August 07 showed earnings per share of 1 cents, beating the estimate of 0 cents. With 80.33K shares outstanding, the current market capitalization sits at 41.34M.
A.I. Advisor
published General Information

General Information

a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
380 Lackawanna Place
Phone
+1 201 343-5202
Employees
31
Web
https://www.nephros.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NVO51.082.32
+4.76%
Novo-Nordisk A/S
RAVE2.820.05
+1.78%
Rave Restaurant Group
HIMX7.270.11
+1.54%
Himax Technologies
CADE34.280.33
+0.97%
Cadence Bank
TCMD12.28-0.16
-1.29%
Tactile Systems Technology

NEPH and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NEPH has been loosely correlated with IMDX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if NEPH jumps, then IMDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEPH
1D Price
Change %
NEPH100%
+34.95%
IMDX - NEPH
34%
Loosely correlated
-2.10%
SGHT - NEPH
33%
Loosely correlated
+19.44%
NEO - NEPH
25%
Poorly correlated
+0.69%
OFIX - NEPH
22%
Poorly correlated
-1.50%
VNRX - NEPH
22%
Poorly correlated
+0.45%
More

Groups containing NEPH

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEPH
1D Price
Change %
NEPH100%
+34.95%
Pharmaceuticals
category (394 stocks)
8%
Poorly correlated
+0.45%
Pharmaceuticals: Other
category (105 stocks)
4%
Poorly correlated
+0.07%